# Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm)

> **NCT03669783** · PHASE3 · RECRUITING · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 110 (estimated)

## Conditions studied

- Childhood Renal Tumor

## Interventions

- **DRUG:** treatment Vincristin
- **DRUG:** treatment Actinomycin-D
- **DRUG:** treatment Doxorubicin
- **DRUG:** treatment Carboplatin
- **DRUG:** Etoposide

## Key facts

- **NCT ID:** NCT03669783
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-03
- **Primary completion:** 2028-10-03
- **Final completion:** 2033-10-03
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2025-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03669783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03669783, "Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03669783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*